2011
DOI: 10.1590/s1984-82502011000300014
|View full text |Cite
|
Sign up to set email alerts
|

Development of agar diffusion method for dosage of gramicidin

Abstract: Gramicidin, an antimicrobial peptide active against Gram positive bacteria, is commonly used in pharmaceutical preparations for topical use. Considering that only the turbidimetric method has been described in the literature, the present study sought to develop and validate an agar diffusion method for the dosage of gramicidin. The method was developed and validated using the Kocuria rhizophila ATCC 9341 as a test microorganism. Two designs were used: a 3x3 parallel-line model, and a 5x1 standard curve. The va… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(12 citation statements)
references
References 10 publications
0
12
0
Order By: Relevance
“…The investigated design did not show any fixed or absolute tendency and relative tendency, nor being necessary to employ any kind of correction or adjustment of the results obtained [24]. The method had appropriate accuracy, as could be confirmed by the values calculated for the β-tolerance interval (Figure 3) for each concentration level, which showed a maximum variation of ± 17.8% for the current two-dose symmetrical design [39,[49][50][51].…”
Section: Accuracy Evaluation Of the Assay Designmentioning
confidence: 72%
See 2 more Smart Citations
“…The investigated design did not show any fixed or absolute tendency and relative tendency, nor being necessary to employ any kind of correction or adjustment of the results obtained [24]. The method had appropriate accuracy, as could be confirmed by the values calculated for the β-tolerance interval (Figure 3) for each concentration level, which showed a maximum variation of ± 17.8% for the current two-dose symmetrical design [39,[49][50][51].…”
Section: Accuracy Evaluation Of the Assay Designmentioning
confidence: 72%
“…While the analysis criteria for individual compounds may show wide variations in the commercial products that could reach 20% in the range, it would be necessary to use a sort of biological test to estimate the net resultant true activity with this complex mixture of microbiologically active entities [3,6,16]. Moreover, Intra-laboratory and inter-laboratory variation mitigation in the microbiological assay might be acquired through the implementation of the international guidelines for the antibiotic assay that include media composition, reagents and assay conditions [39].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The original four calibration curves for nystatin were previously constructed (Table 3) from which the pooled standard curve in Figure 1 was charted. All presented a coefficient of correlation (r) greater than 0.98 according to the Brazilian reference (2003) and FDA (2001) and when compared, no significant difference was found between the intercepts and slopes 39 . This will ensure that the high and low doses -viz 10 and 20 μg/ml -will fall within linear ranges covering overage or decline in the target concentration.…”
Section: Calibration Curve and Linearitymentioning
confidence: 99%
“…However, in the literature, there are a large number of reports describing the use of microbiological assays to assess the potency of many antibiotics (Marona, Schapoval, 1998;Mendez et al, 2005;Gomes, Salgado, 2006;Salgado, Lopes, Lucchesi, 2006;Vaugher, Breier, Schapoval, 2006;Souza et al, 2007;Moreno, Salgado, 2007;Salgado, Tozo, 2007;Schmidt et al, 2008;Lopes, Salgado, 2010;Cazedey, Salgado, 2011;Paim et al, 2011;Solano et al, 2011).…”
Section: Introductionmentioning
confidence: 99%